Medicare Enrolled
Dr. Gordon Brown, DO
Urology Physician · Cherry Hill, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brown from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brown?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brown
Dr. Gordon Brown is an urology physician in Cherry Hill, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brown performed 12,090 Medicare services across 4,030 unique beneficiaries.
Between the years covered by Open Payments, Dr. Brown received a total of $1,183,183 from 50 pharmaceutical and/or device companies across 1035 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brown is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in NJ
$1,183,183 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,090
Medicare services
Top 7% in NJ for urology physician
4,030
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~636 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 5,520 | $3 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,775 | $65 | $188 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
931 | $97 | $274 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
769 | $2 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 741 | $133 | $689 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
338 | $9 | $115 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
245 | $8 | $33 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
245 | $8 | $34 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
160 | $195 | $890 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
160 | $27 | $121 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
125 | $117 | $340 |
| Injection, garamycin, gentamicin, up to 80 mg | 94 | $2 | $3 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
92 | $82 | $274 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
79 | $8 | $15 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
78 | $8 | $13 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
76 | $8 | $33 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
68 | $187 | $1,443 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
51 | $45 | $201 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $45 | $116 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
42 | $20 | $59 |
| PSA test (prostate cancer screening) | 39 | $18 | $76 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
33 | $96 | $2,500 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
31 | $52 | $425 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
29 | $18 | $76 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $125 | $412 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $61 | $183 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
26 | $200 | $1,905 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
24 | $95 | $766 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
22 | $527 | $3,420 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $108 | $336 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
19 | $219 | $3,175 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
19 | $310 | $4,444 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
19 | $269 | $1,400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $145 | $497 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
16 | $28 | $595 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
16 | $2,592 | $22,311 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
15 | $321 | $1,737 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
15 | $171 | $1,275 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
14 | $2 | $13 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
13 | $41 | $97 |
| Partial kidney removal using endoscope Surgical removal of part of the kidney through a small incision using an endoscope. This minimally invasive technique allows for targeted tissue removal without large open incisions. |
12 | $890 | $8,685 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
53.3% medium
46.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,183,183
Total received (2018-2024)
Avg $169,026/year across 7 years
Top 0% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,035
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,102,740 (93.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$77,217 (6.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,226 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$234,861
2023
$259,042
2022
$193,089
2021
$87,266
2020
$117,945
2019
$114,914
2018
$176,067
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$51,117
Bayer Healthcare Pharmaceuticals Inc.
$34,107
Merck Sharp & Dohme LLC
$30,880
AstraZeneca Pharmaceuticals LP
$27,503
Janssen Biotech, Inc.
$21,396
Sumitomo Pharma America, Inc.
$16,016
PFIZER INC.
$15,146
Novartis Pharmaceuticals Corporation
$11,811
Dendreon Pharmaceuticals LLC
$7,900
Janssen Scientific Affairs, LLC
$7,359
Siemens Medical Solutions USA, Inc.
$4,728
PROGENICS PHARMACEUTICALS, INC.
$3,385
Janssen Global Services, LLC
$1,805
UROGEN PHARMA, INC.
$1,562
Medtronic, Inc.
$52
PROCEPT BioRobotics Corporation
$28
Teleflex LLC
$27
Tolmar, Inc.
$20
CONMED Corporation
$18
Top 3 companies account for 49.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$224,959
Bayer HealthCare Pharmaceuticals Inc.
$163,287
Astellas Pharma US Inc
$146,313
Janssen Scientific Affairs, LLC
$137,278
AstraZeneca Pharmaceuticals LP
$115,455
Bayer Healthcare Pharmaceuticals Inc.
$79,784
Merck Sharp & Dohme LLC
$78,665
Sumitomo Pharma America, Inc.
$59,239
Myovant Sciences Inc.
$40,057
PFIZER INC.
$35,434
Novartis Pharmaceuticals Corporation
$11,825
NOVARTIS PHARMACEUTICALS CORPORATION
$10,863
Progenics Pharmaceuticals, Inc.
$10,847
Merck Sharp & Dohme Corporation
$8,541
Dendreon Pharmaceuticals LLC
$8,153
Clovis Oncology, Inc.
$6,465
Janssen Global Services, LLC
$6,438
Johnson & Johnson Health Care Systems Inc.
$5,250
Siemens Medical Solutions USA, Inc.
$4,728
Foundation Medicine, Inc.
$4,103
Ferring Pharmaceuticals Inc.
$3,812
TOLMAR Pharmaceuticals, Inc.
$3,618
PROGENICS PHARMACEUTICALS, INC.
$3,385
UROGEN PHARMA, INC.
$3,243
Pfizer Inc.
$3,000
Amgen Inc.
$2,050
Exelixis Inc.
$1,980
Daiichi Sankyo Inc.
$1,410
Uromedica, Incorporated
$1,390
GENZYME CORPORATION
$566
NeoTract Inc.
$241
Boston Scientific Corporation
$141
Medtronic, Inc.
$124
Seagen Inc.
$94
Teleflex LLC
$74
Prometheus Laboratories Inc.
$42
Antares Pharma, Inc.
$41
Endo Pharmaceuticals Inc.
$38
PROCEPT BioRobotics Corporation
$28
E.R. Squibb & Sons, L.L.C.
$28
AbbVie, Inc.
$28
Myriad Genetic Laboratories, Inc.
$27
AbbVie Inc.
$27
Acerus Pharmaceuticals Corporation
$25
Tolmar, Inc.
$20
CONMED Corporation
$18
UROVANT SCIENCES INC
$14
Avadel Specialty Pharmaceuticals, LLC
$14
Clinigen Inc
$13
Verity Pharmaceuticals Inc.
$12
Top 3 companies account for 45.2% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AMS · AQUABEAM SYSTEM · AVEED · Androgel · Biograph Horizon-3R · CABOMETYX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE CDX · GEMTESA · IMFINZI · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · OPDIVO · ORGOVYX · Otrexup · PADCEV · PLUVICTO · PREMARIN · PROVENGE · PYLARIFY · ProACT · Prolaris · Proleukin · Prolia · RUBRACA · Rubraca · SUTENT · TALZENNA · TOVIAZ · Trelstar · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for urology physician in NJ.
Geographic Context
Urology physicians within 10 mi
279
Per 100K population
53.2
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brown is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NJ), with speaking/promotional industry engagement in the top 0% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brown experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Brown performed 5,520 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brown receive payments from pharmaceutical companies?
Yes. Dr. Brown received a total of $1,183,183 from 50 companies across 1,035 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brown's costs compare to other urology physicians in Cherry Hill?
Dr. Brown's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brown) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cherry Hill
Browse urology physicians in Cherry Hill ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology